IMAGE ANALYSIS GROUP

Image Analysis Group (IAG) is an independent imaging contract research organisation supporting biotechnology and pharmaceutical sponsors with clinical-trial imaging services. Since 2007, the company has supported more than 700 trials, combining imaging expertise, operational delivery and technology to help advance drug development.

IAG provides centralized image management, secure collection and archival, blinded independent central review, quantitative image analysis and imaging charters. Its services span early- and late-phase trials, as well as real-world evidence and AI studies. Sponsors can collect and store imaging data for later analysis, use sensitive imaging biomarkers to inform early development decisions, or receive harmonized acquisition and central reads for pivotal studies. AI-enabled radiomics can also extend the research value of imaging datasets.

The company works across therapeutic areas including oncology, neuroimaging, musculoskeletal conditions, autoimmune diseases, rare diseases, cardiovascular health, and obesity and metabolic diseases. Its bone-health and orthopedic capabilities include assessment using modalities such as DXA, MRI, CT and X-ray.